Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values
Christina S. Thornton(Alberta Health Services), Alain Tremblay(University of Calgary), Mona Shafey(University of Calgary), David H. Evans(University of Alberta), Angela Franko(University of Calgary), Mark R. Gillrie(University of Calgary), Byron M. Berenger(University of Calgary), John Conly(World Health Organization), Yi-Chan Lin(University of Alberta), Michael Bristow(University of Calgary), Kevin Huntley(University of Calgary), Kevin Fonseca(University of Calgary), Marcus Povitz(University of Calgary)
Cited by 47
Related Papers
Physical interventions to interrupt or reduce the spread of respiratory viruses
|Cochrane Database of Systematic Reviews|2011|835
Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015
|The Journal of Infectious Diseases|2017|170
Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response
|Frontiers in Immunology|2024|52
Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018
|Clinical Infectious Diseases|2018|51
The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health
|European Respiratory Review|2021|45